<DOC>
	<DOCNO>NCT01300078</DOCNO>
	<brief_summary>This Phase 1 , open label , randomize clinical trial enroll 40 generally healthy , postmenopausal woman age 40-65 year old . Women randomize one two oral dos MF101 4 week . Participants recruit 3 clinical site United States .</brief_summary>
	<brief_title>A Clinical Trial Assessing Safety MF101 Hot Flushes</brief_title>
	<detailed_description>MF101 oral , non-hormonal , botanical agent investigate treatment menopausal hot flash .</detailed_description>
	<mesh_term>Hot Flashes</mesh_term>
	<criteria>Inclusion Criteria ( partial list ) : Postmenopausal woman age 4065 year . Provide inform consent . Currently receive medical care health care provider . Other inclusion apply . Exclusion Criteria ( partial list ) : History malignancy nonmelanoma skin cancer cervical cancer diagnose fully treat less 5 year screen . Unexplained uterine bleeding within 6 month prior Screening . History deep vein thrombosis pulmonary embolism . Active liver disease history impair . Active gallbladder disease . Other exclusion apply .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Hot Flashes</keyword>
	<keyword>Hot Flushes</keyword>
	<keyword>Vasomotor Symptoms</keyword>
	<keyword>Menopausal Symptoms</keyword>
</DOC>